Page 27 - Read Online

Chamberlain G, Rainbow DB, Hunter KM, Smith AN, Latte G, Noli A, Gabbas A. Cytotoxic T-lymphocyte
Di Genova G, Herr MH, Dahlman I, Payne F, Smyth D, antigen-4 (CTLA-4) gene polymorphism and susceptibility to
Lowe C, Twells RC, Howlett S, Healy B, Nutland S, non-Hodgkin’s lymphoma. Am J Hematol 2004;76:14-8.
Rance HE, Everett V, Smink LJ, Lam AC, Cordell HJ, 27. Mao H, Zhang L, Yang Y, Zuo W, Bi Y, Gao W, Deng B, Sun J,
Walker NM, Bordin C, Hulme J, Motzo C, Cucca F, Shao Q, Qu X. New insights of CTLA-4 into its biological function
Hess JF, Metzker ML, Rogers J, Gregory S, Allahabadia A, in breast cancer. Curr Cancer Drug Targets 2010;10:728-36.
Nithiyananthan R, Tuomilehto-Wolf E, Tuomilehto J, 28. Shastry BS. SNP alleles in human disease and evolution.
Bingley P, Gillespie KM, Undlien DE, Rønningen KS, Guja C, J Hum Genet 2002;47:561-6.
Ionescu-Tîrgovişte C, Savage DA, Maxwell AP, Carson DJ, 29. Linsley PS, Ledbetter JA. The role of the CD28 receptor
Patterson CC, Franklyn JA, Clayton DG, Peterson LB, during T cell responses to antigen. Annu Rev Immunol
Wicker LS, Todd JA, Gough SC. Association of the T-cell 1993;11:191-212.
regulatory gene CTLA4 with susceptibility to autoimmune 30. Brunner-Weinzierl MC, Hoff H, Burmester GR. Multiple
disease. Nature 2003;423:506-11.
20. Han SZ, Zhang SH, Li R, Zhang WY, Li Y. The functions for CD28 and cytotoxic T lymphocyte antigen-4 during
different phases of T cell responses: Implications for arthritis and
common -318C/T polymorphism in the promoter region of autoimmune diseases. Arthritis Res Ther 2004;6:45-54.
CTLA4 gene is associated with reduced risk of ophthalmopathy
in Chinese Graves’ patients. Int J Immunogenet 2006;33:281-7. 31. Zheng J, Yu X, Jiang L, Xiao M, Bai B, Lu J, Zhou Y.
21. Anjos SM, Polychronakos C. Functional evaluation of the Association between the Cytotoxic T-lymphocyte antigen
4+ 49G > A polymorphism and cancer risk: a meta-analysis.
autoimmunity-associated CTLA4 gene: The effect of the (AT) BMC Cancer 2010;10:522.
repeat in the 3’untranslated region (UTR). J Autoimmun
2006;27:105-9. 32. Li D, Zhang Q, Xu F, Fu Z, Yuan W, Li D, Pang D. Association
22. Barreto M, Santos E, Ferreira R, Fesel C, Fontes MF, of CTLA-4 gene polymorphisms with sporadic breast cancer
risk and clinical features in Han women of northeast China.
Pereira C, Martins B, Andreia R, Viana JF, Crespo F, Mol Cell Biochem 2012;364:283-90.
Vasconcelos C, Ferreira C, Vicente AM. Evidence for CTLA4
as a susceptibility gene for systemic lupus erythematosus. Eur 33. Li H, Fu ZK, Wang LH, Li DL, Wu N, Zhang J, Li DJ.
Association of cytotoxic T lymphocyte antigen-4 gene
J Hum Genet 2004;12:620-6.
23. Ghaderi A, Yeganeh F, Kalantari T, Talei AR, Pezeshki AM, polymorphisms with susceptibility to breast cancer. Xi Bao Yu
Fen Zi Mian Yi Xue Za Zhi 2008;24:282-4. (in Chinese)
Doroudchi M, Dehaghani AS. Cytotoxic T lymphocyte 34. Bi Y, Wei L, Mao HT, Zhang L, Zuo WS. Expressions of Fas,
antigen-4 gene in breast cancer. Breast Cancer Res Treat
2004;86:1-7. CTLA-4 and RhoBTB2 genes in breast carcinoma and their
24. Erfani N, Razmkhah M, Talei AR, Pezeshki AM, Doroudchi M, relationship with clinicopathological factors. Zhonghua Zhong
Liu Za Zhi 2008;30:749-53. (in Chinese)
Monabati A, Ghaderi A. Cytotoxic T lymphocyte antigen-4
promoter variants in breast cancer. Cancer Genet Cytogenet
2006;165:114-20. How to cite this article: Farbod M, Shiryazdi SM, Harazi H,
25. Zheng C, Huang D, Liu L, Björkholm M, Holm G, Yi Q, Nazari T, Sheikhha MH. Association between the cytotoxic
Sundblad A. Cytotoxic T-lymphocyte antigen-4 microsatellite T-lymphocyte antigen-4 polymorphisms and breast cancer risk and
polymorphism is associated with multiple myeloma. Br J prognosis. J Cancer Metastasis Treat 2015;1:16-20.
Haematol 2001;112:216-8. Received: 29-11-2014; Accepted: 19-02-2015.
26. Monne M, Piras G, Palmas A, Arru L, Murineddu M, Source of Support: Nil, Confl ict of Interest: None declared.

20 Journal of Cancer Metastasis and Treatment ¦ Volume 1 ¦ Issue 1 ¦ April 15, 2015 ¦